Morning Movers 7/8: TRGT, HNAB, AMGN, NTWK, FDO Higher; ARYX, XNPT, ARNA, AXL Lower
ARYx Therapeutics, Inc. (NASDAQ: ARYX) 54.9% LOWER; getting slammed in pre-open trading after announcing that a trial of anticoagulant agent tecarfarin did not achieve the primary endpoint of superiority over leading oral anticoagulant warfarin. Click here for the full report.
Targacept, Inc. (Nasdaq: TRGT) 43.4% HIGHER; announced that AstraZeneca (NYSE: AZN) has informed Targacept that it plans to conduct further development of AZD3480 (TC-1734) for attention deficit/hyperactivity disorder and has agreed to make a $10 million milestone payment to Targacept.
Hana Biosciences (Nasdaq: HNAB) 19.2% HIGHER; continuing higher this morning following yesterday's 50% surge.
Amgen (Nasdaq: AMGN) 15.5% HIGHER; announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,049 patients with advanced breast cancer met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa. Click here for the full report. The stock also had some analyst action: had its price target raised at both Piper Jaffray and Baird.
NetSol Technologies, Inc. (NASDAQ: NTWK) 13.6% HIGHER; today announced that its subsidiary in the Asia Pacific region has been awarded a turnkey contract valued in excess of $1 million for setting up the IT infrastructure, as well as the development of application software to automate and enhance the tax collection systems, for the Government of Sindh Province in Pakistan. Click here for the full report.
XenoPort, Inc. (Nasdaq: XNPT) 12.3% LOWER; announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a price to the public of $19.00 per share. XenoPort has granted the underwriters a 30-day option to purchase up to an additional 375,000 shares of common stock to cover over-allotments, if any.
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) 10.3% LOWER; priced its public offering of 12,500,000 shares of its common stock at a public offering price of $4.17 per share.
Ruby Tuesday, Inc. (NYSE: RT) 9.1% HIGHER; reports Q4 EPS of $0.28, 9 cents better than the analyst estimate of $0.19. Revenue for the quarter was $317.3 million, versus the consensus of $303.95 million. Same store sales fell 3.2% during the quarter. Sees FY10 EPS of $0.50-$0.65, versus the consensus of $0.55. Same store sales are expected to be down 2.5-3.5%.
Family Dollar (NYSE: FDO) 8.6% HIGHER; reports Q3 EPS of $0.62, 3 cents better than the analyst estimate of $0.59. Revenue for the quarter was $1.84 billion, versus the consensus of $1.84 billion. Sales in comparable stores increased 6.2%. Family Dollar sees Q4 sales to increase between 4% and 6% and expects comparable store sales will increase 2% to 4%. It sees Q4 EPS $0.39 to $0.43 versus $0.39. Family Dollar sees FY09 EPS $2.03 and $2.07 compared to the analyst view of $2.00.
American Axle (NYSE: AXL) 8% LOWER; continuing lower once again amid bankruptcy fears.
To get this report daily, visit http://www.streetinsider.com/entities/After-Hours+Movers.
Targacept, Inc. (Nasdaq: TRGT) 43.4% HIGHER; announced that AstraZeneca (NYSE: AZN) has informed Targacept that it plans to conduct further development of AZD3480 (TC-1734) for attention deficit/hyperactivity disorder and has agreed to make a $10 million milestone payment to Targacept.
Hana Biosciences (Nasdaq: HNAB) 19.2% HIGHER; continuing higher this morning following yesterday's 50% surge.
Amgen (Nasdaq: AMGN) 15.5% HIGHER; announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,049 patients with advanced breast cancer met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa. Click here for the full report. The stock also had some analyst action: had its price target raised at both Piper Jaffray and Baird.
NetSol Technologies, Inc. (NASDAQ: NTWK) 13.6% HIGHER; today announced that its subsidiary in the Asia Pacific region has been awarded a turnkey contract valued in excess of $1 million for setting up the IT infrastructure, as well as the development of application software to automate and enhance the tax collection systems, for the Government of Sindh Province in Pakistan. Click here for the full report.
XenoPort, Inc. (Nasdaq: XNPT) 12.3% LOWER; announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a price to the public of $19.00 per share. XenoPort has granted the underwriters a 30-day option to purchase up to an additional 375,000 shares of common stock to cover over-allotments, if any.
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) 10.3% LOWER; priced its public offering of 12,500,000 shares of its common stock at a public offering price of $4.17 per share.
Ruby Tuesday, Inc. (NYSE: RT) 9.1% HIGHER; reports Q4 EPS of $0.28, 9 cents better than the analyst estimate of $0.19. Revenue for the quarter was $317.3 million, versus the consensus of $303.95 million. Same store sales fell 3.2% during the quarter. Sees FY10 EPS of $0.50-$0.65, versus the consensus of $0.55. Same store sales are expected to be down 2.5-3.5%.
Family Dollar (NYSE: FDO) 8.6% HIGHER; reports Q3 EPS of $0.62, 3 cents better than the analyst estimate of $0.59. Revenue for the quarter was $1.84 billion, versus the consensus of $1.84 billion. Sales in comparable stores increased 6.2%. Family Dollar sees Q4 sales to increase between 4% and 6% and expects comparable store sales will increase 2% to 4%. It sees Q4 EPS $0.39 to $0.43 versus $0.39. Family Dollar sees FY09 EPS $2.03 and $2.07 compared to the analyst view of $2.00.
American Axle (NYSE: AXL) 8% LOWER; continuing lower once again amid bankruptcy fears.
To get this report daily, visit http://www.streetinsider.com/entities/After-Hours+Movers.
You May Also Be Interested In
- Unusual 11 Mid-Day Movers 05/25: (GNOM) (UPI) (RPRX) Higher; (TLB) (DCTH) (PAY) Lower
- Trading Radar for 05/29: Eltek (ELTK), Sanderson Farms (SAFM), Chimera Investment (CIM), Cavco Industries (CVCO) Report
- Top 10 News Items 5/21-5/25: Eurozone Fears Remain, But Stocks Charge Higher; Facebook Continues to Be Sold; HP Investors Cheer Q2 Results
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Piper Jaffray, Robert W Baird, Morning Movers, BankruptcySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
